Author

B. Farkas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:protein folding & dynamics· 1 Assay:structural biology· 1

Frequent Co-Authors

A. Bartha· 1 shared B. Kiss· 1 shared B. Sidders· 1 shared D. Veres· 1 shared D. Young· 1 shared G. Lukacs· 1 shared H. Grubmuller· 1 shared H. Tordai· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bartha

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA Damage Response inhibitors

O. Papp, V. Jordan, S. Hetey, R. Balazs, A. Bartha, N. N. Ordasi, S. Kamp, B. Farkas, J. Mettetal, J. R. Dry, D. Young, D. Veres, B. Sidders, K. C. Bulusu

The paper introduces a network biology-driven simulation method to predict effective drug combinations and identify biomarkers for DNA Damage Response inhibitors using cancer cell avatars.

bioRxiv · Nov 20, 2023Cancer Biology

Nanomechanics combined with HDX reveal allosteric drug binding sites of CFTR NBD1

R. Padanyi, B. Farkas, H. Tordai, B. Kiss, H. Grubmuller, N. Soya, G. Lukacs, M. Kellermayer, T. Hegedus

This study combines nanomechanics and HDX to identify allosteric binding sites in {Delta}F508-CFTR NBD1, revealing how BIA stabilizes the protein.

bioRxiv · Aug 20, 2021Biophysics